InVitae (NVTA) Misses Q4 EPS by 16c

InVitae (NYSE: NVTA) reported Q4 EPS of ($0.90), $0.16 worse than the analyst estimate of ($0.74). Revenue for the quarter came in at $121.6 million versus the consensus estimate of $126.65 million.

GUIDANCE:

InVitae sees 2022 revenue of $640 million, versus the consensus of $638 million.

For earnings history and earnings-related data on InVitae (NVTA) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
• Marchex (MCHX) Reports In-Line Q2 EPS